Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Economic impact of hypoglycemia among insulin-treated patients with diabetes.

Sussman M, Sierra JA, Garg S, Bode B, Friedman M, Gill M, Kaufman F, Vigersky R, Menzin J.

J Med Econ. 2016 Jun 13:1-23. [Epub ahead of print]

PMID:
27292016
2.

Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.

Lin I, Sung J, Sanchez RJ, Mallya UG, Friedman M, Panaccio M, Koren A, Neumann P, Menzin J.

J Manag Care Spec Pharm. 2016 Jun;22(6):685-98. doi: 10.18553/jmcp.2016.22.6.685.

3.

Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States.

Huang H, Taylor DC, Carson RT, Sarocco P, Friedman M, Munsell M, Blum SI, Menzin J.

Manag Care. 2016 Feb;25(2):41-8.

4.

Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis.

Lang K, Federico V, Patel AA, Munsell M, Nelson WW, Owens G, Mody SH, Schein J, Menzin J.

J Comp Eff Res. 2016 Jan;5(1):39-48. doi: 10.2217/cer.15.48. Epub 2015 Dec 21.

PMID:
26690040
5.

Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records.

Sussman M, Trocio J, Best C, Mirkin S, Bushmakin AG, Yood R, Friedman M, Menzin J, Louie M.

BMC Womens Health. 2015 Aug 13;15:58. doi: 10.1186/s12905-015-0217-y.

6.

The impact of multimorbidity on quality of life among midlife women: findings from a U.S. nationally representative survey.

Lang K, Alexander IM, Simon J, Sussman M, Lin I, Menzin J, Friedman M, Dutwin D, Bushmakin AG, Thrift-Perry M, Altomare C, Hsu MA.

J Womens Health (Larchmt). 2015 May;24(5):374-83. doi: 10.1089/jwh.2014.4907.

7.

Inhaled nitric oxide in term/late preterm neonates with hypoxic respiratory failure: estimating the financial impact of earlier use.

Konduri GG, Menzin J, Frean M, Lee T, Potenziano J, Singer J.

J Med Econ. 2015 Aug;18(8):612-8. doi: 10.3111/13696998.2015.1038270. Epub 2015 May 7.

PMID:
25853867
8.

Symptom burden and quality of life among women with HER2(+) metastatic breast cancer.

Mayer M, Lang K, Hurvitz S, Lalla D, Federico V, Brammer M, Menzin J, Tripathy D.

Breast J. 2015 Mar-Apr;21(2):208-10. doi: 10.1111/tbj.12374. Epub 2015 Feb 6. No abstract available.

PMID:
25655357
9.

Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data.

Menzin J, Preblick R, Friedman M, Menzin J, Frean M, Jacqueline Kwong W.

Hosp Pract (1995). 2014 Oct;42(4):59-74. doi: 10.3810/hp.2014.10.1143.

PMID:
25502130
10.

A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.

Phillips AL, Munsell MJ, Menzin J, Dangond F, Locklear JC.

Value Health. 2014 Nov;17(7):A392. doi: 10.1016/j.jval.2014.08.867. Epub 2014 Oct 26. No abstract available.

11.

Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy.

Lang K, Hao Y, Huang H, Lin I, Rogerio JW, Menzin J.

J Comp Eff Res. 2014 Sep;3(5):481-90. doi: 10.2217/cer.14.39.

PMID:
25350800
12.

Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.

Huang H, Taylor DC, Carson RT, Sarocco P, Friedman M, Munsell M, Blum SI, Menzin J.

J Med Econ. 2015 Apr;18(4):283-94. doi: 10.3111/13696998.2014.979291.

PMID:
25333331
13.

Economic impact of psychiatric relapse and recidivism among adults with schizophrenia recently released from incarceration: a Markov model analysis.

Lin I, Muser E, Munsell M, Benson C, Menzin J.

J Med Econ. 2015 Mar;18(3):219-29. doi: 10.3111/13696998.2014.971161. Epub 2014 Nov 26.

PMID:
25266814
14.

Use of blood products in patients with anticoagulant-related major bleeding: an analysis of inhospital outcomes.

Menzin J, Sussman M, Nichols C, Friedman M, Zbrozek A.

Am J Health Syst Pharm. 2014 Oct 1;71(19):1635-45. doi: 10.2146/ajhp130729.

PMID:
25225449
15.

Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis.

Lang K, Patel AA, Munsell M, Bookhart BK, Mody SH, Schein JR, Menzin J.

J Thromb Thrombolysis. 2015 May;39(4):434-42. doi: 10.1007/s11239-014-1108-z.

16.

Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis.

Lang K, Bozkaya D, Patel AA, Macomson B, Nelson W, Owens G, Mody S, Schein J, Menzin J.

BMC Health Serv Res. 2014 Jul 28;14:329. doi: 10.1186/1472-6963-14-329.

17.
18.

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy.

Menzin J, Sussman M, Munsell M, Zbrozek A.

Clinicoecon Outcomes Res. 2014 Jun 10;6:297-302. doi: 10.2147/CEOR.S63200. eCollection 2014.

19.

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data.

Zilberberg MD, Shorr AF, Huang H, Chaudhari P, Paly VF, Menzin J.

BMC Infect Dis. 2014 Jun 5;14:310. doi: 10.1186/1471-2334-14-310.

20.

National trends in advanced outpatient diagnostic imaging utilization: an analysis of the medical expenditure panel survey, 2000-2009.

Lang K, Huang H, Lee DW, Federico V, Menzin J.

BMC Med Imaging. 2013 Nov 26;13:40. doi: 10.1186/1471-2342-13-40.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk